Teva (TEVA) stock forecast for 2022

The forecast has been updated: January 13, 2022 8:59


Teva stock price online today

Analyst Target Price

11.39

Dividend Date

12.12.2017

Ex Dividend Date

27.11.2017

Last Split Factor

Last Split Date

01.01.1970

Should you buy or sell Teva stock stock today? What is the projected target price level for 2022? How much will it cost in 2022? Teva stock Stock Monthly Prediction for January, February, March, April, May, July, July, August, September, October, November and December 2022.

We predict the dynamics of the stock market value using resonant artificial intelligence systems.

Technical, fundamental analyzes, news background, general geopolitical situation in the world and other factors are taken into account.

Forecasts are adjusted once a day taking into account the price change of the previous day.

To date, analysts have a $11.39 target price for Teva stock stock.

Today 200 Day Moving Average is the resistance level (9.78 $).

50 Day Moving Average is the resistance level (8.9 $).




TEVA Forecast for 2022

Month Rate Forecast MIN Rate MAX Rate Volati-
lity, %
Feb 9.72 8.72 10.62 17.86 %
Mar 10.08 9.06 10.95 17.23 %
Apr 9.71 9.08 10.68 14.97 %
May 10.34 9.17 11.57 20.74 %
Jun 9.90 8.80 10.78 18.36 %
Jul 9.55 9.04 10.16 10.98 %
Aug 9.99 8.73 10.47 16.64 %
Sep 10.18 9.79 10.95 10.57 %
Oct 9.51 8.83 10.29 14.20 %
Nov 8.01 7.48 8.29 9.74 %
Dec 8.05 7.08 8.35 15.25 %

The forecasts table above shows the forecast values of the company's stock price for each month. The Rate Forecast column displays the Optimal Average Forecast Price. The MIN Rate column displays a pessimistic forecast for this month. “MAX Rate” is an optimistic forecast. The % Volatility column represents the approximate monthly volatility of Teva stock.


Teva overview

Teva Address

5 BAZEL ST, P O B 3190, PETACH TIKVA, IL

Market Capitalization

9 485 886 000 $

EBITDA

4 296 000 000

PE Ratio

13.03

PEG Ratio

0.736

Dividend Per Share

0

Dividend Yield

0

EPS

0.66

Quarterly Earnings Growth YOY

0.469

Quarterly Revenue Growth YOY

-0.023

Trailing PE

13.03

Forward PE

3.061

EV To Revenue

1.907

EV To EBITDA

8.65

52 Week High

13.3

52 Week Low

7.78

50 Day Moving Average

8.9

200 Day Moving Average

9.78

Shares Outstanding

1103010000

Shares Float

Shares Short Prior Month

Short Ratio

Percent Insiders

Percent Institutions

Teva stock forecast for this year


Teva stock forecast for Feb 2022.
Estimated Average Forecasted Teva Price: 9.72. Positive monthly dynamics of the instrument is expected with 17.863% volatility is expected.

Pessimistic forecast: 8.72

Optimistic: 10.62


Teva stock forecast for Mar 2022.
Estimated Average Forecasted Teva Price: 10.08. Positive monthly dynamics of the instrument is expected with 17.231% volatility is expected.

Pessimistic forecast: 9.06

Optimistic: 10.95


Teva stock forecast for Apr 2022.
Estimated Average Forecasted Teva Price: 9.71. Negative monthly dynamics of the instrument is expected with 14.971% volatility is expected.

Pessimistic forecast: 9.08

Optimistic: 10.68


Teva stock forecast for May 2022.
Estimated Average Forecasted Teva Price: 10.34. Positive monthly dynamics of the instrument is expected with 20.744% volatility is expected.

Pessimistic forecast: 9.17

Optimistic: 11.57


Teva stock forecast for Jun 2022.
Estimated Average Forecasted Teva Price: 9.90. Negative monthly dynamics of the instrument is expected with 18.356% volatility is expected.

Pessimistic forecast: 8.80

Optimistic: 10.78


Teva stock forecast for Jul 2022.
Estimated Average Forecasted Teva Price: 9.55. Negative monthly dynamics of the instrument is expected with 10.977% volatility is expected.

Pessimistic forecast: 9.04

Optimistic: 10.16


Teva stock forecast for Aug 2022.
Estimated Average Forecasted Teva Price: 9.99. Positive monthly dynamics of the instrument is expected with 16.641% volatility is expected.

Pessimistic forecast: 8.73

Optimistic: 10.47


Teva stock forecast for Sep 2022.
Estimated Average Forecasted Teva Price: 10.18. Positive monthly dynamics of the instrument is expected with 10.566% volatility is expected.

Pessimistic forecast: 9.79

Optimistic: 10.95


Teva stock forecast for Oct 2022.
Estimated Average Forecasted Teva Price: 9.51. Negative monthly dynamics of the instrument is expected with 14.201% volatility is expected.

Pessimistic forecast: 8.83

Optimistic: 10.29


Teva stock forecast for Nov 2022.
Estimated Average Forecasted Teva Price: 8.01. Negative monthly dynamics of the instrument is expected with 9.737% volatility is expected.

Pessimistic forecast: 7.48

Optimistic: 8.29


Teva stock forecast for Dec 2022.
Estimated Average Forecasted Teva Price: 8.05. Positive monthly dynamics of the instrument is expected with 15.254% volatility is expected.

Pessimistic forecast: 7.08

Optimistic: 8.35



Other Healthcare sector assets

Name Symbol Last Close Price Change
Abbott Laboratories
ABT 128.16 (14.01.2022) -1.15 %
AbbVie Inc.
ABBV 135.87 (14.01.2022) 1.76 %
Aeterna Zentaris Inc.
AEZS 0.3597 (14.01.2022) 0.14 %
Allakos Inc.
ALLK 7.64 (14.01.2022) -2.68 %
Allogene Therapeutics, Inc.
ALLO 13.28 (14.01.2022) 11.04 %
Amgen Inc.
AMGN 235.36 (14.01.2022) 1.95 %
Aphria Inc.
APHA 15.38 (07.05.2021) 0.00 %
Atara Biotherapeutics, Inc.
ATRA 16.07 (14.01.2022) 12.93 %
Aurora Cannabis Inc.
ACB 5.51 (14.01.2022) -0.54 %
Becton Dickinson and Company
BDX 262.62 (14.01.2022) -0.41 %
Biogen Inc.
BIIB 239.3 (14.01.2022) 1.11 %
Biohaven Pharmaceutical Holding Company Ltd.
BHVN 122.17 (14.01.2022) -0.46 %
BioNTech SE
BNTX 196 (14.01.2022) -3.44 %
bluebird bio, Inc.
BLUE 8.73 (14.01.2022) 2.46 %
Boston Scientific Corp.
BSX 44.86 (14.01.2022) 0.65 %
Bristol-Myers Squibb Company
BMY 64.93 (14.01.2022) 0.51 %
Canopy Growth Corp.
CGC 8.4 (14.01.2022) -0.12 %
Castle Biosciences, Inc.
CSTL 36.69 (14.01.2022) -0.73 %
CLOVER HEALTH INVESTMENTS, CORP
CLOV 3.16 (07.01.2022) -5.67 %
Eli Lilly and Company
LLY 244.12 (14.01.2022) -2.22 %
Emergent BioSolutions Inc.
EBS 52.22 (14.01.2022) 5.54 %
Exelixis, Inc.
EXEL 18.12 (14.01.2022) 1.97 %
G1 Therapeutics, Inc.
GTHX 10.11 (14.01.2022) 6.42 %
Gilead Sciences, Inc.
GILD 71.77 (14.01.2022) -0.15 %
GlaxoSmithKline plc
GSK 45.47 (14.01.2022) 0.91 %
GoodRx Holdings, Inc.
GDRX 26.85 (14.01.2022) -1.32 %
GW Pharmaceuticals plc.
GWPH 218.96 (05.05.2021) 0.00 %
Incyte Corp.
INCY 74.88 (14.01.2022) 1.67 %
Inovio Pharmaceuticals, Inc.
INO 4.75 (14.01.2022) 3.04 %
Johnson & Johnson
JNJ 167.84 (14.01.2022) -0.55 %
Medtronic plc.
MDT 108.55 (14.01.2022) -0.21 %
Merck & Co., Inc.
MRK 81.38 (14.01.2022) 0.07 %
Moderna, Inc.
MRNA 204.73 (14.01.2022) -2.59 %
Novartis AG
NVS 90.55 (14.01.2022) -0.08 %
Novavax, Inc.
NVAX 110.82 (14.01.2022) -1.39 %
ObsEva SA
OBSV 1.92 (14.01.2022) 1.59 %
OrganiGram Holdings Inc.
OGI 1.64 (14.01.2022) -1.20 %
Pfizer Inc.
PFE 54.95 (14.01.2022) -1.06 %
Regeneron Pharmaceuticals, Inc.
REGN 615.24 (14.01.2022) -0.14 %
Sanofi
SNY 51.93 (14.01.2022) 2.37 %
Schrodinger, Inc.
SDGR 30.69 (14.01.2022) 3.40 %
Senseonics Holdings, Inc.
SENS 2.84 (14.01.2022) 2.16 %
Sorrento Therapeutics, Inc.
SRNE 4.56 (14.01.2022) 5.31 %
Stryker Corp.
SYK 266.71 (14.01.2022) -0.44 %
Sundial Growers Inc.
SNDL 0.564 (14.01.2022) 0.64 %
Teva Pharmaceutical Industries Lim. (TEVA)
TEVA 9.17 (14.01.2022) -0.33 %
Thermo Fisher Scientific Inc.
TMO 594.8 (14.01.2022) -1.01 %
Tilray, Inc.
TLRY 6.86 (14.01.2022) -0.15 %
UnitedHealth Group, Inc.
UNH 468.69 (14.01.2022) 0.27 %
Veeva Systems Inc.
VEEV 223.85 (14.01.2022) -1.45 %
Zomedica Corp.
ZOM 0.35 (14.01.2022) 4.45 %
Zynerba Pharmaceuticals, Inc.
ZYNE 2.63 (14.01.2022) 3.14 %


Denial of responsibility:

The portal leoprophet.com is not responsible for the loss of your money as a result of your use of the information contained on the site, including data, quotes, charts and forecasts. Operations in the stock, foreign exchange and commodity markets involve a high level of risk, and you are solely responsible for your operations. Only speculate with money that you can afford to lose. All prices and forecasts for stocks, indices, futures are indicative and should not be trade dependent. The portal is not responsible for any losses that you may incur as a result of using this data.